BIO 2008: Oz bio online
03 June, 2008 by Staff WritersAustralia will have a virtual and a physical presence at BIO
BIO 2008: Oz biotech - state of the nation
02 June, 2008 by Kate McDonaldBIO 2008, the world's largest conference for the biotechnology industry, is being held in San Diego from June 16. In our annual preview, we take a look at how the Australian sector is travelling.
CSL head to chair pharma group
27 May, 2008 by Kate McDonaldBrian McNamee named as co-chair of Government's pharma industry advisory group.
Prototype vaccine for West Nile virus
21 May, 2008 by Kate McDonaldReplikun and UQ agreement to develop vaccine for West Nile virus.
Biotech and the rise of the patent troll
20 May, 2008 by Kate McDonaldThere is a beast stalking the world of intellectual property and biological inventions: the patent troll.
VivaGel well tolerated: Starpharma
12 May, 2008 by Kate McDonaldStarpharma has released positive results from VivaGel clinical trial.
Evado signs distribution deal
14 April, 2008 by Staff WritersSeerPharma to market new clinical software in Australia and south-east Asia
Slimeballs and eyeballs: hagfish and the evolution of the eye
11 April, 2008 by Kate McDonaldHagfish may be ferociously ugly little creatures, but they can teach us much about the evolution of the vertebrate eye.
Hedgehog and the need for speed
01 April, 2008 by Fiona WylieModel organisms such as zebrafish are vitally important in answering basic questions of developmental cell biology and signalling, and those built for distance and not speed may just have a few more prickles.
Living fossil still calls Australia home
27 March, 2008 by Staff WritersFossil bones of the Djarthia, our earliest known marsupial, have been linked to South America's extant Monito del Monte.
Two advance to BIO
26 March, 2008 by Kate McDonaldTwo local scientists are off to the BIO convention in June after winning the Advance BioBusiness award.
You say tomato ...
17 March, 2008 by Mauricio EspinozaUS crop scientists discover gene that controls fruit shape.
Big week for Australian biotechs part II
13 March, 2008 by Kate McDonaldCytopia goes into Phase II trials for vascular disrupting agent while Benitec licensee agrees to develop RNAi-based therapy for hepatitis C.
Big week for Australian biotechs
12 March, 2008 by Kate McDonaldProgen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results.
Bionomics begins Phase 1 trial
27 February, 2008 by Staff WritersThe first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent.
